Literature DB >> 2110371

Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system.

D Cotariu1, J L Zaidman, S Evans.   

Abstract

(1) Valproic acid is an anticonvulsant agent widely used in the management of various forms of epilepsy, including absence, myoclonic and tonic-clonic seizures. (2) It also has anticonvulsant potency in a wide variety of animal models of epilepsy. (3) This action is generally thought to be exerted through modulation of the activity of the endogenous inhibitory neurotransmitter, gamma-aminobutyric acid. (4) Evidence that valproic acid interacts with the gamma-aminobutyric acid system is presented. (5) Interactions of valproic acid with other neurotransmitters, i.e. aspartate, glutamate, taurine, serotonin, as well as with cyclic nucleotides and hormones are also considered. (6) Direct effects of valproic acid on excitable membranes and its relationships with analgesia are outlined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110371     DOI: 10.1016/0301-0082(90)90010-e

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  9 in total

1.  Epilepsy and medication effects on the pattern visual evoked potential.

Authors:  Andrew M Geller; H Ken Hudnell; Bradley V Vaughn; John A Messenheimer; William K Boyes
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

2.  The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates.

Authors:  J F Dixon; L E Hokin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

3.  QPEEG analysis of the effects of sodium valproate on adult Chinese patients with generalized tonic-clonic seizures.

Authors:  Jiamei Guo; Dan Wang; Min Ren; Bo Xiong; Zengyou Li; Xuefeng Wang; Kebin Zeng
Journal:  Metab Brain Dis       Date:  2014-05-10       Impact factor: 3.584

4.  Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures.

Authors:  M Nilsson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

Review 5.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.

Authors:  Nicholas J Delva; Deborah L Brooks; Michael Franklin; Khalid al-Said; Emily R Hawken; Zul Merali; J Stuart Lawson; Arun V Ravindran
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

7.  Valproate and sodium currents in cultured hippocampal neurons.

Authors:  R J Van den Berg; P Kok; R A Voskuyl
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

8.  Association of polycystic ovaries with the use of valproic Acid in jordanian epileptic patients.

Authors:  S Otoom; M Nusier; M Hasan; H Hadidi; R Samawi; A M Younes; M Darweesh; N R Boulatova
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

9.  Predictable enriched environment prevents development of hyper-emotionality in the VPA rat model of autism.

Authors:  Mônica R Favre; Deborah La Mendola; Julie Meystre; Dimitri Christodoulou; Melissa J Cochrane; Henry Markram; Kamila Markram
Journal:  Front Neurosci       Date:  2015-06-02       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.